CCND1 and hepatocellular carcinoma: reported that MED23 knockdown in HCC cells upregulated p16, which in turn arrested cell-cycle progression at the G1/S transition by inhibiting the activity of cyclin-dependent protein kinase, cyclin D1 complex (24).